Boulder’s 300+ biotech companies and 8,000 life sciences employees need specialized preclinical CRO services to accelerate drug discovery. Anilocus provides comprehensive research support from pharmacokinetics to regulatory compliance, helping University of Colorado spinouts and established pharmaceutical companies like AGC Biologics navigate FDA requirements in Colorado’s thriving biotechnology ecosystem.
Atlanta biotech companies accelerate drug discovery with Anilocus CRO services, leveraging Georgia’s growing life sciences ecosystem anchored by CDC, Emory University, and innovative developments like Science Square with specialized preclinical research expertise supporting pharmaceutical innovation.
Los Angeles biotech companies accelerate drug discovery with Anilocus CRO services, leveraging the city’s growing life sciences ecosystem anchored by Amgen, Kite Pharma, and world-class research universities with specialized preclinical research expertise for emerging biotech hub success.
Chicago’s biotech companies leverage Anilocus CRO services to accelerate drug discovery in America’s emerging pharmaceutical hub, where 790 life sciences companies generate $28 billion economic impact. Anilocus offers specialized preclinical research expertise from compound characterization through regulatory submission, supporting growing biotech startups alongside established giants like AbbVie and Abbott Laboratories.
Research Triangle Park biotech companies accelerate drug development with Anilocus CRO services, leveraging the world’s largest research park ecosystem, home to seven top-10 global CROs and 790 life sciences companies with specialized preclinical research expertise.
Philadelphia’s biotech companies leverage Anilocus CRO services to accelerate drug discovery in “Cellicon Valley,” home to 10% of global cell and gene therapy companies, with specialized regulatory expertise for FDA proximity and comprehensive preclinical research support.
Laboratory researchers isolate and preserve peripheral blood mononuclear cells in research facilities during sample processing workflows for immunological studies. This essential protocol enables long-term storage of immune cells while maintaining viability and functionality for vaccine research, biomarker studies, and therapeutic monitoring. The process involves density gradient separation, cell counting, and
Bold ideas and breakthrough research. Expert analysis on the innovations and drug development for the most important people in the world: patients.
Use this form to send your questions to our research team about our preclinical contract research services.
We are here to help!
